Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Epithelial Ovarian Cancer: Focus on Targeted Therapy
Guest Editors: Maurie M. Markman, Jalid Sehouli, Charles F. Levenback, and Dennis S. Chi- Epithelial Ovarian Cancer: Focus on Targeted Therapy, M. Markman, Jalid Sehouli, Charles F. Levenback, and Dennis S. Chi
Volume 2010 (2010), Article ID 171425, 1 page - When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place?, Igor E. Martinek and Sean Kehoe
Volume 2010 (2010), Article ID 852028, 6 pages - Treatment for Recurrent Ovarian Cancer—At First Relapse, Kimio Ushijima
Volume 2010 (2010), Article ID 497429, 7 pages - Targeted Therapy in Ovarian Cancer, Lyndsay J. Willmott and John P. Fruehauf
Volume 2010 (2010), Article ID 740472, 9 pages - Targeted Therapies in Epithelial Ovarian Cancer, Nicanor I. Barrena Medel, Jason D. Wright, and Thomas J. Herzog
Volume 2010 (2010), Article ID 314326, 9 pages - Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma, C. Blake Gilks
Volume 2010 (2010), Article ID 740968, 7 pages - A Current Review of Targeted Therapeutics for Ovarian Cancer, Susana M. Campos and Sue Ghosh
Volume 2010 (2010), Article ID 149362, 11 pages - Antivascular Therapy for Epithelial Ovarian Cancer, Francois P. Duhoux and Jean-Pascal Machiels
Volume 2010 (2010), Article ID 372547, 16 pages - Targeting the EGF Receptor for Ovarian Cancer Therapy, Reema Zeineldin, Carolyn Y. Muller, M. Sharon Stack, and Laurie G. Hudson
Volume 2010 (2010), Article ID 414676, 11 pages - Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges, Doris R. Siwak, Mark Carey, Bryan T. Hennessy, Catherine T. Nguyen, Mollianne J. McGahren Murray, Laura Nolden, and Gordon B. Mills
Volume 2010 (2010), Article ID 568938, 20 pages - Downregulation of Epidermal Growth Factor Receptor Expression Contributes to -TEA's Proapoptotic Effects in Human Ovarian Cancer Cell Lines, Ming-Chieh Shun, Weiping Yu, Sook-Kyung Park, Bob G. Sanders, and Kimberly Kline
Volume 2010 (2010), Article ID 824571, 11 pages - The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer, Lilian T. Gien and Helen J. Mackay
Volume 2010 (2010), Article ID 151750, 6 pages - BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer, Katherine V. Clark-Knowles, Anna M. O'Brien, and Johanne I. Weberpals
Volume 2010 (2010), Article ID 891059, 9 pages - Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer, Marie-Claude Beauchamp, Amber Yasmeen, Ariane Knafo, and Walter H. Gotlieb
Volume 2010 (2010), Article ID 257058, 11 pages - The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer, L. D. Kellenberger, J. E. Bruin, J. Greenaway, N. E. Campbell, R. A. Moorehead, A. C. Holloway, and J. Petrik
Volume 2010 (2010), Article ID 514310, 13 pages - Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer, Noriyuki Takai and Hisashi Narahara
Volume 2010 (2010), Article ID 458431, 6 pages - Disrupting Ovarian Cancer Metastatic Colonization: Insights from Metastasis Suppressor Studies, Shaheena Khan, Jennifer L. Taylor, and Carrie W. Rinker-Schaeffer
Volume 2010 (2010), Article ID 286925, 7 pages - Repeated Intraperitoneal -Radioimmunotherapy of Ovarian Cancer in Mice, Jörgen Elgqvist, Håkan Andersson, Holger Jensen, Helena Kahu, Sture Lindegren, Elisabet Warnhammar, and Ragnar Hultborn
Volume 2010 (2010), Article ID 394913, 5 pages